MedTrace Logo

Efficacy Evaluation of an ODF Iron Supplement Vs an Iron Supplement in Capsules in Subjects with Mild Anemia

NCT05989984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2025-01-08

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of a new iron supplement with orodispersible formulation vs an iron supplement in capsules in subjects with mild anemia.

Conditions

  • Iron Deficiencies

Interventions

DIETARY_SUPPLEMENT

ODF Iron Supplement

ODF iron supplement will be admistered daily for 8 weeks.

DIETARY_SUPPLEMENT

Iron Supplement in Capsules

Iron supplement in capsule will be admistered daily for 8 weeks.

Sponsors & Collaborators

  • Informapro Srl

    collaborator OTHER

  • IBSA Farmaceutici Italia Srl

    lead INDUSTRY

Principal Investigators

  • Silvia Angeletti · Operative Research Unit of Clinical Laboratory

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-29
Primary Completion
2024-08-08
Completion
2024-08-08

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05989984 on ClinicalTrials.gov